Evidence map›Paper›PMID 24872377›Full record

Trial reportAnnals of the rheumatic diseases2015

Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA).

Maxime Dougados, Martin Soubrier, Elodie Perrodeau, Laure Gossec, Françoise Fayet, Mélanie Gilson, Marie-Hélène Cerato, Sophie Pouplin, René-Marc Flipo, Laurent Chabrefy and 13 more

Registry-linked trialOpen access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Annals of the rheumatic diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03715595 (The Treat-to-target Study of Rheumatoid Arthritis Based on Smart System of Disease Management), which is not on this map. Cited by 50 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 7 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03715595 naunknown statusnot on this mapstarted 2018, after this paper: background citation

The Treat-to-target Study of Rheumatoid Arthritis Based on Smart System of Disease Management(SSDM) : A Randomized Controlled Multicenter Trial

TypeinterventionalSponsorPeking University People's HospitalRan2018 to 2020Enrolled2,200ConditionsRheumatoid ArthritisArmsSSDM group
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 7 syntheses or guidelines pooled it, 158 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Observational
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Massage therapy in rheumatoid arthritis.Rheumatology international · 2025
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 19 institutions in 1 country.

Maxime DougadosRhumatologie B, Cochin Hospital, Paris, France; rené Descartes University INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, France.
Martin SoubrierDepartment of Rheumatology, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Elodie PerrodeauDepartment of Epidemiology, INSERM U738, APHP, Hôtel-Dieu Hospital, Paris, France.
Laure GossecRheumatology Department, UPMC, Univ Paris 06, APHP, Pitié-Salpêtrière Hospital, Paris, France.
Françoise FayetDepartment of Rheumatology, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Mélanie GilsonDepartment of Rheumatology, CHU Sud Hospital, Grenoble, France.
Marie-Hélène CeratoDepartment of Rheumatology, Purpan Hospital, Toulouse, France.
Sophie PouplinDepartment of Rheumatology, Bois-Guillaume CHU, Rouen, France.
René-Marc FlipoDepartment of Rheumatology, CHU Roger Salengro Hospital, University of Lille 2, Lille, France.
Laurent ChabrefyDepartment of Rheumatology, Marseille, France.
Gael MouterdeDepartment of Rheumatology, Lapeyronie Hospital, Montpellier, France.
Liana Euller-ZieglerDepartment of Rheumatology, L'Archet Hospital, NICE, France.
Thierry SchaeverbekeDepartment of Rheumatology, Pellegrin Hospital, Bordeaux, France.
Bruno FautrelDepartment of Rheumatology, APHP, Pitié-Salpêtrière Hospital, Paris, France.
Alain SarauxDepartment of Rheumatology, and EA2216, CHU Brest, Université de Bretagne Occidentale, France.
Isabelle Chary-ValckenaereDepartment of Rheumatology, Nancy Hospital, Nancy, France.
Gérard ChalesMedecine Faculty, Department of Rheumatology, South Hospital, Rennes 1 University, Rennes, France.
Emmanuelle DernisDepartment of Rheumatology, Le Mans Hospital, Le Mans, France.
Pascal RichetteUniversité Paris Diderot, UFR médicale, Paris , France; APHP Hôpital Lariboisiére, Fédération de Rhumatologie, Paris, France.
Xavier MarietteDepartment of Rheumatology, APHP, Bicêtre Hospital, Le Kremlin-Bicetre, France.
Francis BerenbaumDepartment of Rheumatology, Univ Paris 06 and INSERM UMRS_938, DHU i2B, APHP Saint- Antoine Hospital, Paris, France.
Jean SibiliaDepartment of Rheumatology, Hautepierre CHU, Fédération de médecine translationnelle, UMR INSERM 1109, Strasbourg, France.
Philippe RavaudDepartment of Epidemiology, APHP, Bichat Hospital, Paris, France.
Assistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRPitié-Salpêtrière Hospital · FRBicêtre Hospital · FRCentre de Recherche Saint-Antoine · FRCentre Hospitalier du Mans · FRCentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de Rouen · FRCentre Hospitalier Universitaire de Toulouse · FRHôpital Lapeyronie · FRHôpital l'Archet · FRHôpital Maison Blanche · FRHôpital Pellegrin · FRHôpital Roger Salengro · FRImmuno-Rhumathologie moléculaireSociété Française de Rhumatologie · FRUniversité Claude Bernard Lyon 1 · FRUniversité Paris Cité · FRUniversité Rennes 2 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesRheumatoid arthritis (RA) patients are at an increased risk of developing comorbid conditions. A close monitoring of the disease targeting a status of low disease activity is associated with a better outcome. The aim of this trial was to evaluate the impact of a nurse-led programme on comorbidities and the impact of patient self-assessment of disease activity on the management of RA.

methodsWe enrolled 970 patients (mean age 58 years, 79% women) in a prospective, randomised, controlled, open-label, 6-month trial. In the comorbidity group (n=482), the nurse checked comorbidities and sent the programme results to the attending physicians. In the self-assessment group (n=488), the nurse taught the patient how to calculate his/her Disease Activity Score which had to be reported on a booklet to be shared with the treating rheumatologist. The number of measures taken for comorbidities and the percentage of patients recording a change (initiation, switch or increased dose) in disease-modifying antirheumatic drugs (DMARDs) in the 6 months follow-up period of the study defined the outcomes of the trial.

resultsThe number of measures taken per patient was statistically higher in the comorbidity group: 4.54±2.08 versus 2.65±1.57 (p<0.001); incidence rate ratio: 1.78 (1.61-1.96) and DMARD therapy was changed more frequently in the self-assessment group: 17.2% versus 10.9% (OR=1.70 (1.17; 2.49), p=0.006).

conclusionsThis study demonstrates the short-term benefit of a nurse-led programme on RA comorbidity management and the impact of patient self-assessment of disease activity on RA treatment intensification. TRIAL REGISTRATION NUMBER: NCT #01315652.

Indexed as

AgedAntirheumatic AgentsArthritis, RheumatoidComorbidityDiabetes MellitusDisease ManagementDyslipidemiasFemaleFractures, BoneHumansHypertensionMaleMiddle AgedPatient Outcome AssessmentPractice Patterns, Nurses'Self CareAntirheumatic AgentsCardiovascular DiseaseNursingRheumatoid Arthritis

Identifiers

PMID24872377
PMCPMC4552897
OpenAlexW2104617957

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.